There are 2 listed companies in liraglutide concept, one of which is traded on the Shanghai Stock Exchange, and the other one is traded on the Shenzhen Stock Exchange. traded.
Hanyu Pharmaceutical: In 2014, it obtained an invention patent for the synthesis of liraglutide and produced liraglutide API.
Tonghua Dongbao: The liraglutide injection project is undergoing pilot production and pharmacological and toxicological research, and plans to apply for clinical application at the end of 2016.